Back to Search
Start Over
DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
- Source :
- Evensen, J, Hansen, H S, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2013, ' DAHANCA 9-A randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', The European cancer congress, Amsterdam, Netherlands, 30/09/2013 ., Evensen, J F, Sand Hansen, H, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2019, ' DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', Acta Oncologica, vol. 58, no. 10, pp. 1502-1505 . https://doi.org/10.1080/0284186X.2019.1629012, Evensen, J F, Sand Hansen, H, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2019, ' DAHANCA 9-a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', Acta oncologica (Stockholm, Sweden), vol. 58, no. 10, pp. 1502-1505 . https://doi.org/10.1080/0284186X.2019.1629012, University of Southern Denmark
- Publication Year :
- 2019
- Publisher :
- Informa UK Limited, 2019.
-
Abstract
- Following the DAHANCA 5 trial [1], which demonstrated the benefit of the hypoxic radiosensitizer Nimorazole, and the DAHANCA 6&7 trial, which demonstrated that accelerated fractionation added signi...
- Subjects :
- Oncology
medicine.medical_specialty
Radiosensitizer
Nimorazole
business.industry
Dose fractionation
Hematology
General Medicine
030218 nuclear medicine & medical imaging
law.invention
03 medical and health sciences
DAHANCA
0302 clinical medicine
Multicenter study
Randomized controlled trial
law
030220 oncology & carcinogenesis
Internal medicine
Medicine
Radiology, Nuclear Medicine and imaging
In patient
business
Head and neck
medicine.drug
Subjects
Details
- ISSN :
- 1651226X and 0284186X
- Volume :
- 58
- Database :
- OpenAIRE
- Journal :
- Acta Oncologica
- Accession number :
- edsair.doi.dedup.....6b44368a5711fa3bb678d9c76b484bb0
- Full Text :
- https://doi.org/10.1080/0284186x.2019.1629012